Back to Search
Start Over
Clinical Benefit of First-Line Cemiplimab in Patients with Locally Advanced NSCLC: Subgroup Analysis from EMPOWER-Lung 1
- Publication Year :
- 2021
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.od......9651..c2b7ddfcb6f552faa2282fde5d16c90f